An experimental form of immunotherapy could identify and eliminate cancer-driving blood cells harboring a specific mutation while sparing most healthy cells, making it a promising therapeutic strategy for myelofibrosis and related cancers, a…

Eli Lilly’s AJ1-11095, an experimental JAK2 inhibitor recently licensed from Ajax Therapeutics, may be safe and effective at easing symptoms of myelofibrosis in patients whose disease has stopped responding to first-generation JAK2…

A few months ago, I walked 100 kilometers in northwestern Spain. That’s about 60 miles. It was the final trek of the legendary Camino de Santiago trail that starts in Sarria and ends in Santiago…